Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 191

1.

Single cell behavior in metastatic primary mammary tumors correlated with gene expression patterns revealed by molecular profiling.

Wang W, Wyckoff JB, Frohlich VC, Oleynikov Y, Hüttelmaier S, Zavadil J, Cermak L, Bottinger EP, Singer RH, White JG, Segall JE, Condeelis JS.

Cancer Res. 2002 Nov 1;62(21):6278-88. Erratum in: Cancer Res 2002 Dec 1;62(23):7132.

2.

Correlation of beta-actin messenger RNA localization with metastatic potential in rat adenocarcinoma cell lines.

Shestakova EA, Wyckoff J, Jones J, Singer RH, Condeelis J.

Cancer Res. 1999 Mar 15;59(6):1202-5.

3.
4.

A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.

Fritzmann J, Morkel M, Besser D, Budczies J, Kosel F, Brembeck FH, Stein U, Fichtner I, Schlag PM, Birchmeier W.

Gastroenterology. 2009 Jul;137(1):165-75. doi: 10.1053/j.gastro.2009.03.041.

PMID:
19328798
5.

A critical step in metastasis: in vivo analysis of intravasation at the primary tumor.

Wyckoff JB, Jones JG, Condeelis JS, Segall JE.

Cancer Res. 2000 May 1;60(9):2504-11.

6.

Fibronectin is distinctly downregulated in murine mammary adenocarcinoma cells with high metastatic potential.

Urtreger AJ, Werbajh SE, Verrecchia F, Mauviel A, Puricelli LI, Kornblihtt AR, Bal de Kier Joffé ED.

Oncol Rep. 2006 Dec;16(6):1403-10.

PMID:
17089068
8.

Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrix.

Eckhardt BL, Parker BS, van Laar RK, Restall CM, Natoli AL, Tavaria MD, Stanley KL, Sloan EK, Moseley JM, Anderson RL.

Mol Cancer Res. 2005 Jan;3(1):1-13.

9.

Metastasis-associated differences in gene expression in a murine model of osteosarcoma.

Khanna C, Khan J, Nguyen P, Prehn J, Caylor J, Yeung C, Trepel J, Meltzer P, Helman L.

Cancer Res. 2001 May 1;61(9):3750-9.

10.

Cell motility of tumor cells visualized in living intact primary tumors using green fluorescent protein.

Farina KL, Wyckoff JB, Rivera J, Lee H, Segall JE, Condeelis JS, Jones JG.

Cancer Res. 1998 Jun 15;58(12):2528-32.

11.
12.

Suppression of human ovarian carcinoma metastasis by the metastasis-suppressor gene, BRMS1.

Zhang S, Lin QD, DI W.

Int J Gynecol Cancer. 2006 Mar-Apr;16(2):522-31.

PMID:
16681721
13.
15.

Behavior of metastatic and nonmetastatic breast tumors in old mice.

Gravekamp C, Sypniewska R, Gauntt S, Tarango M, Price P, Reddick R.

Exp Biol Med (Maywood). 2004 Jul;229(7):665-75.

PMID:
15229361
16.

Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion.

Williams TM, Medina F, Badano I, Hazan RB, Hutchinson J, Muller WJ, Chopra NG, Scherer PE, Pestell RG, Lisanti MP.

J Biol Chem. 2004 Dec 3;279(49):51630-46.

17.

Differential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis.

Hao X, Sun B, Hu L, Lähdesmäki H, Dunmire V, Feng Y, Zhang SW, Wang H, Wu C, Wang H, Fuller GN, Symmans WF, Shmulevich I, Zhang W.

Cancer. 2004 Mar 15;100(6):1110-22.

18.

The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression.

Fayard B, Bianchi F, Dey J, Moreno E, Djaffer S, Hynes NE, Monard D.

Cancer Res. 2009 Jul 15;69(14):5690-8. doi: 10.1158/0008-5472.CAN-08-4573.

20.

Global expression profiling identifies signatures of tumor virulence in MMTV-PyMT-transgenic mice: correlation to human disease.

Qiu TH, Chandramouli GV, Hunter KW, Alkharouf NW, Green JE, Liu ET.

Cancer Res. 2004 Sep 1;64(17):5973-81.

Items per page

Supplemental Content

Support Center